| |
| Issue |
Title |
| |
| No 10 (2024) |
Own experience of using combination therapy in the first line of treatment of metastatic renal cell carcinoma |
Abstract
PDF (Rus)
|
|
T. V. Ustinova, A. Yu. Chanaeva, A. A. Paichadze, A. V. Levshakova, L. V. Bolotina, V. M. Ivanykina, A. A. Fedenko |
| |
| No 22 (2023) |
Treatment of metastatic сlear cell renal cell carcinoma: focus on a group of patients with favourable prognosis |
Abstract
PDF (Rus)
|
|
A. A. Rumyantsev |
| |
| No 11 (2023) |
Immune checkpoint inhibitors in bladder cancer therapy: the experience with avelumab |
Abstract
PDF (Rus)
|
|
A. A. Gritskevich, T. P. Baitman, S. V. Mishugin, A. Yu. Popov, D. M. Yagudaev, L. A. Falaleeva, I. G. Rusakov |
| |
| No 22 (2022) |
Atezolizumab (Tecentriq) as first-line therapy in patients with metastatic urothelial carcinoma |
Abstract
PDF (Rus)
|
|
A. A. Gritskevich, T. P. Baitman, S. V. Mishugin, A. Yu. Popov, V. A. Oganyan, I. G. Rusakov, A. A. Kostin |
| |
| No 22 (2022) |
Reactualization of sunitinib in the treatment of metastatic renal cell carcinoma |
Abstract
PDF (Rus)
|
|
A. A. Gritskevich, T. P. Baitman, A. Yu. Popov, I. G. Rusakov, N. A. Karelskaya, A. A. Chevina, P. Zholboldu |
| |
| No 22 (2022) |
Treatment of metastatic bladder cancer: current and historical aspects |
Abstract
PDF (Rus)
|
|
A. A. Rumyantsev |
| |
| No 9 (2022) |
Efficacy of the 1st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens |
Abstract
PDF (Rus)
|
|
K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov |
| |
| No 9 (2022) |
Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use |
Abstract
PDF (Rus)
|
|
A. A. Gritskevich, A. Yu. Popov, I. G. Rusakov, E. K. Vozniy, V. A. Makarov, D. I. Gridnev, T. P. Baitman, S. V. Mishugin, I. V. Novikova, S. V. Khromova |
| |
| No 20 (2021) |
Experience of successful use of axitinib in therapy of metastatic renal cell carcinoma after immunotargeted therapy |
Abstract
PDF (Rus)
|
|
A. A. Rumyantsev |
| |
| No 20 (2021) |
Efficacy of enzalutamide in patients with metastatic hormone-sensitive and castration-refractory prostate cancer: authors’ experience |
Abstract
PDF (Rus)
|
|
T. V. Ustinova, L. V. Bolotina, A. A. Paichadze, A. A. Kachmazov, A. A. Fedenko, A. D. Kaprin |
| |
| No 20 (2021) |
Metastatic renal cell carcinoma, the possibility of targeted therapy. Case. |
Abstract
PDF (Rus)
|
|
K. V. Menshikov, A. A. Izmailov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov |
| |
| No 9 (2021) |
Does sunitinib still have a place in the current recommendations for the systemic treatment of advanced renal cell carcinoma? |
Abstract
PDF (Rus)
|
|
M. I. Volkova, S. A. Kalinin |
| |
| No 4S (2021) |
The use of a new combination of avelumab + axitinib in patients with metastatic kidney cancer in the first line of treatment |
Abstract
PDF (Rus)
|
|
B. Ya. Alekseev, I. M. Shevchuk, V. Р. Aleshin |
| |
| No 4S (2021) |
The new approaches to the treatment of castration- resistant prostate cancer: PARP inhibitors |
Abstract
PDF (Rus)
|
|
А. А. Gritskevich, I. G. Rusakov, Т. Р. Baitman, S. V. Mishugin |
| |
| No 20 (2020) |
Еfficiacy and safety of radium-223 in the treatment of metastatic castration-resistant prostate cancer |
Abstract
PDF (Rus)
|
|
I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, S. V. Mishugin |
| |
| No 20 (2020) |
Modern antiandrogenic therapy of patients with castration-resistant prostate cancer without metastases |
Abstract
PDF (Rus)
|
|
S. V. Popov |
| |
| No 20 (2020) |
Choice of treatment options for metastatic hormone-sensitive prostate cancer |
Abstract
PDF (Rus)
|
|
R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets |
| |
| No 20 (2020) |
The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy |
Abstract
PDF (Rus)
|
|
I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, S. V. Mishugin |
| |
| No 9 (2020) |
The role of sunitinib in the therapy of metastatic renal cell carcinoma |
Abstract
PDF (Rus)
|
|
I. G. Rusakov, A. A. Gritskevich, T. P. Baitman, A. N. Shipilova, S. V. Mishugin |
| |
| 1 - 19 of 19 Items |
|
